523 related articles for article (PubMed ID: 27764576)
1. Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective.
Alibert S; N'gompaza Diarra J; Hernandez J; Stutzmann A; Fouad M; Boyer G; Pagès JM
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):301-309. PubMed ID: 27764576
[TBL] [Abstract][Full Text] [Related]
2. The development of efflux pump inhibitors to treat Gram-negative infections.
Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
[TBL] [Abstract][Full Text] [Related]
3. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
Nikaido H; Pagès JM
FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
[TBL] [Abstract][Full Text] [Related]
4. Efflux in Gram-negative bacteria: what are the latest opportunities for drug discovery?
Gil-Gil T; Laborda P; Ochoa-Sánchez LE; Martínez JL; Hernando-Amado S
Expert Opin Drug Discov; 2023 Jun; 18(6):671-686. PubMed ID: 37199662
[TBL] [Abstract][Full Text] [Related]
5. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
Hasdemir U
Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
[TBL] [Abstract][Full Text] [Related]
6. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
Blair JM; Richmond GE; Piddock LJ
Future Microbiol; 2014; 9(10):1165-77. PubMed ID: 25405886
[TBL] [Abstract][Full Text] [Related]
7. Efflux-mediated drug resistance in bacteria.
Li XZ; Nikaido H
Drugs; 2004; 64(2):159-204. PubMed ID: 14717618
[TBL] [Abstract][Full Text] [Related]
8. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
Pagès JM; Amaral L; Fanning S
Curr Med Chem; 2011; 18(19):2969-80. PubMed ID: 21651484
[TBL] [Abstract][Full Text] [Related]
9. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.
Lomovskaya O; Bostian KA
Biochem Pharmacol; 2006 Mar; 71(7):910-8. PubMed ID: 16427026
[TBL] [Abstract][Full Text] [Related]
10. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
Li XZ; Plésiat P; Nikaido H
Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
[TBL] [Abstract][Full Text] [Related]
11. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.
Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV
Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084
[TBL] [Abstract][Full Text] [Related]
12. RND efflux pumps in Gram-negative bacteria; regulation, structure and role in antibiotic resistance.
Colclough AL; Alav I; Whittle EE; Pugh HL; Darby EM; Legood SW; McNeil HE; Blair JM
Future Microbiol; 2020 Jan; 15():143-157. PubMed ID: 32073314
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
[TBL] [Abstract][Full Text] [Related]
14. The hydrophobic trap-the Achilles heel of RND efflux pumps.
Aron Z; Opperman TJ
Res Microbiol; 2018; 169(7-8):393-400. PubMed ID: 29146106
[TBL] [Abstract][Full Text] [Related]
15. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
Schweizer HP
Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
[TBL] [Abstract][Full Text] [Related]
16. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists.
Aeschlimann JR
Pharmacotherapy; 2003 Jul; 23(7):916-24. PubMed ID: 12885104
[TBL] [Abstract][Full Text] [Related]
17. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
Wang Y; Venter H; Ma S
Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
[TBL] [Abstract][Full Text] [Related]
19. Optimization of a novel series of pyranopyridine RND efflux pump inhibitors.
Aron Z; Opperman TJ
Curr Opin Microbiol; 2016 Oct; 33():1-6. PubMed ID: 27232955
[TBL] [Abstract][Full Text] [Related]
20. RND efflux pump and its interrelationship with quorum sensing system.
Liang ZB; Chen YM; Chen Y; Cheng YY; Zhang LH
Yi Chuan; 2016 Oct; 38(10):894-901. PubMed ID: 27806930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
